Michael Shawn Moran - Feb 28, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role: EVP, Chief Commercial Officer
Signature: /s/ Brian Cahill, Attorney-in-Fact
Stock symbol: EGRX
Transactions as of: Feb 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/2/2022, 05:11 PM
Previous filing: Feb 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EGRX	Common Stock	Award	$0	+10.4K	+47.89%	$0.00	32.1K	Feb 28, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Content

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting of the unit. The shares issuable in respect of such RSUs shall vest with respect to 25% of the shares of common stock on each of the one, two, three and four-year anniversaries of February 28, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.